Qualitative Neuromuscular Monitoring: How to Optimize the Use of a Peripheral Nerve Stimulator to Reduce the Risk of Residual Neuromuscular Blockade

Current Anesthesiology Reports

Volumn 6, Issue 2, 2016, Pages 164-169

  Thilen, Stephan R ^a   Bhananker, Sanjay M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Neuromuscular block antagonism; Neuromuscular block reversal; Neuromuscular monitoring; Qualitative neuromuscular monitoring; Residual neuromuscular blockade; Residual paralysis

Indexed keywords

EID: 85010035676     PISSN: 21676275     EISSN: 15233855     Source Type: Journal    
DOI: 10.1007/s40140-016-0155-8     Document Type: Article

References (51)

1. Naguib M, Kopman AF, Ensor JE. Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis. Br J Anaesth. 2007;98:302–16.
2. Hayes AH, Mirakhur RK, Breslin DS, Reid JE, McCourt KC. Postoperative residual block after intermediate-acting neuromuscular blocking drugs. Anaesthesia. 2001;56:312–8.
3. Murphy GS, Szokol JW, Marymont JH, Franklin M, Avram MJ, Vender JS. Residual paralysis at the time of tracheal extubation. Anesth Analg. 2005;100:1840–5.
4. Cammu G, de Baerdemaeker L, den Blauwen N, de Mey JC, Struys M, Mortier E. Postoperative residual curarization with cisatracurium and rocuronium infusions. Eur J Anaesthesiol. 2002;19:129–34.
5. •• Fortier LP, McKeen D, Turner K, de Médicis É, Warriner B, Jones PM, Chaput A, Pouliot JF, Galarneau A. The RECITE Study: a Canadian prospective, multicenter study of the incidence and severity of residual neuromuscular blockade. Anesth Analg. 2015;121:366–72. This study provides the most recent estimate of residual neuromuscular blockade in the context of contemporary practice using conventional nerve stimulators and neostigmine. The study methodology was appropriate and the results underscore the need for improved practice.
6. Viby-Mogensen J, Jensen NH, Engbaek J, Ording H, Skovgaard LT, Chraemmer-Jørgensen B. Tactile and visual evaluation of the response to train-of-four nerve stimulation. Anesthesiology. 1985;63:440–3.
7. Murphy G, Brull S. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg. 2010;111:120–8.
8. Kopman AF, Zank LM, Ng J, Neuman GG. Antagonism of cisatracurium and rocuronium block at a tactile train-of-four count of 2: should quantitative assessment of neuromuscular function be mandatory? Anesth Analg. 2004;98:102–6 table of contents.
9. Kopman AF, Lawson D. Milliamperage requirements for supramaximal stimulation of the ulnar nerve with surface electrodes. Anesthesiology. 1984;61:83–5.
10. Tammisto T, Wirtavuori K, Linko K. Assessment of neuromuscular block: comparison of three clinical methods and evoked electromyography. Eur J Anaesthesiol. 1988;5:1–8.
11. Dubois PE, Gourdin M, Jamart J, Broka SM, Eucher P, D’Hollander A. Early and late parameters describing the offset of neuromuscular blockade are highly intercorrelated. Acta Anaesthesiol Scand. 2012;56:76–82.
12. Kim K, Cheong M, Lee H, Lee J. Tactile assessment for the reversibility of rocuronium-induced neuromuscular blockade during propofol or sevoflurane anesthesia. Anesth Analg. 2004;99:1080–5.
13. Kitajima T, Ishii K, Kobayashi T, Ogata H. Differential effects of vecuronium on the thumb and the big toe muscles evaluated by acceleration measurement. J Anesth. 1994;8:143–5.
14. Kern SE, Johnson JO, Orr JA, Westenskow DR. Clinical analysis of the flexor hallucis brevis as an alternative site for monitoring neuromuscular block from mivacurium. J Clin Anesth. 1997;9:383–7.
15. Saitoh Y, Koitabashi Y, Makita K, Tanaka H, Amaha K. Train-of-four and double burst stimulation fade at the great toe and thumb. Can J Anaesth = Journal Canadien D’anesthésie. 1997;44:390–5.
16. Saitoh Y, Fujii Y, Takahashi K, Makita K, Tanaka H, Amaha K. Recovery of post-tetanic count and train-of-four responses at the great toe and thumb. Anaesthesia. 1998;53:244–8.
17. Heier T, Hetland S. A comparison of train-of-four monitoring: mechanomyography at the thumb vs acceleromyography at the big toe. Acta Anaesthesiol Scand. 1999;43:550–5.
18. • Thilen SR, Hansen BE, Ramaiah R, Kent CD, Treggiari MM, Bhananker SM. Intraoperative neuromuscular monitoring site and residual paralysis. Anesthesiology. 2012;117:964–72. This study showed that current practice of facial nerve stimulation and evaluation of eye muscle twitches is not safe because of a 5-fold increased incidence of residual block. The study also reported an almost 4-fold increased incidence of residual block for overweight and obese patients, most likely because of inadequate dose adjustment of NMBDs for these patients.
19. Stiffel P, Hameroff SR, Blitt CD, Cork RC. Variability in assessment of neuromuscular blockade. Anesthesiology. 1980;52:436–7.
20. Caffrey RR, Warren ML, Becker KE. Neuromuscular blockade monitoring comparing the orbicularis oculi and adductor pollicis muscles. Anesthesiology. 1986;65:95–7.
21. Donati F, Meistelman C, Plaud B. Vecuronium neuromuscular blockade at the diaphragm, orbicularis oculi and adductor pollicis muscles. Can J Anaesth. 1990;37:S13.
22. Sayson SC, Mongan PD. Onset of action of mivacurium chloride. A comparison of neuromuscular blockade monitoring at the adductor pollicis and the orbicularis oculi. Anesthesiology. 1994;81:35–42.
23. Debaene B, Meistelman C, Beaussier M, Lienhart A. Visual estimation of train-of-four responses at the orbicularis oculi and posttetanic count at the adductor pollicis during intense neuromuscular block. Anesth Analg. 1994;78:697–700.
24. Rimaniol JM, Dhonneur G, Sperry L, Duvaldestin P. A comparison of the neuromuscular blocking effects of atracurium, mivacurium, and vecuronium on the adductor pollicis and the orbicularis oculi muscle in humans. Anesth Analg. 1996;83:808–13.
25. Abdulatif M, El-Sanabary M. Blood flow and mivacurium-induced neuromuscular block at the orbicularis oculi and adductor pollicis muscles. Br J Anaesth. 1997;79:24–8.
26. Larsen PB, Gätke MR, Fredensborg BB, Berg H, Engbaek J, Viby-Mogensen J. Acceleromyography of the orbicularis oculi muscle II: comparing the orbicularis oculi and adductor pollicis muscles. Acta Anaesthesiol Scand. 2002;46:1131–6.
27. Hattori H, Saitoh Y, Nakajima H, Sanbe N, Akatu M, Murakawa M. Visual evaluation of fade in response to facial nerve stimulation at the eyelid. J Clin Anesth. 2005;17:276–80.
28. • Donati F. Neuromuscular monitoring: more than meets the eye. Anesthesiology. 2012;117:934–6. Excellent editorial which explains how to mitigate the risk of intraoperative monitoring of eye muscles.
29. King M, Sujirattanawimol N, Danielson DR, Hall BA, Schroeder DR, Warner DO. Requirements for muscle relaxants during radical retropubic prostatectomy. Anesthesiology. 2000;93:1392–7.
30. Kopman AF, Naguib M. Laparoscopic surgery and muscle relaxants: is deep block helpful? Anesth Analg. 2015;120:51–8.
31. Plaud B, Debaene B, Donati F, Marty J. Residual paralysis after emergence from anesthesia. Anesthesiology. 2010;112:1013–22.
32. Brull S, Murphy G. Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness. Anesth Analg. 2010;111:129–40.
33. Kirkegaard H, Heier T, Caldwell J. Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block. Anesthesiology. 2002;96:45–50.
34. Brull SJ, Naguib M, Miller RD. Residual neuromuscular block: rediscovering the obvious. Anesth Analg. 2008;107:11–4.
35. Brull S, Kopman A, Naguib M. Management principles to reduce the risk of residual neuromuscular blockade. Curr Anesthesiol Rep. 2013;3:130–8.
36. Fuchs-Buder T, Meistelman C, Alla F, Grandjean A, Wuthrich Y, Donati F. Antagonism of low degrees of atracurium-induced neuromuscular blockade: dose-effect relationship for neostigmine. Anesthesiology. 2010;112:34–40.
37. Fuchs-Buder T, Baumann C, De Guis J, Guerci P, Meistelman C. Low-dose neostigmine to antagonise shallow atracurium neuromuscular block during inhalational anaesthesia: a randomised controlled trial. Eur J Anaesthesiol. 2013;30:594–8.
38. Xue FS, Tong SY, Liao X, Liu JH, An G, Luo LK. Dose-response and time course of effect of rocuronium in male and female anesthetized patients. Anesth Analg. 1997;85:667–71.
39. • Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Shear TD, Vender JS, Parikh KN, Patel SS, Patel A. Residual Neuromuscular Block in the Elderly: Incidence and Clinical Implications. Anesthesiology. 2015;123:1322–36. Good study which demonstrated that age is a risk factor for residual neuromuscular blockade, presumably because of inadequate dose adjustment of NMBDs for these patients.
40. Adamus M, Hrabalek L, Wanek T, Gabrhelik T, Zapletalova J. Influence of age and gender on the pharmacodynamic parameters of rocuronium during total intravenous anesthesia. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011;155:347–53.
41. Meyhoff CS, Lund J, Jenstrup MT, Claudius C, Sørensen AM, Viby-Mogensen J, Rasmussen LS. Should dosing of rocuronium in obese patients be based on ideal or corrected body weight? Anesth Analg. 2009;109:787–92.
42. Weinstein JA, Matteo RS, Ornstein E, Schwartz AE, Goldstoff M, Thal G. Pharmacodynamics of vecuronium and atracurium in the obese surgical patient. Anesth Analg. 1988;67:1149–53.
43. •• Donati F. Residual paralysis: a real problem or did we invent a new disease? Can J Anaesth. 2013;60:714–29. Excellent review article which clearly explains why neostigmine should not be administered early.
44. Miller R, Van Nyhuis L. Eger En, Vitez T, Way W. Comparative times to peak effect and durations of action of neostigmine and pyridostigmine. Anesthesiology. 1974;41:27–33.
45. Young WL, Matteo RS, Ornstein E. Duration of action of neostigmine and pyridostigmine in the elderly. Anesth Analg. 1988;67:775–8.
46. Engbaek J, Ostergaard D, Viby-Mogensen J. Double burst stimulation (DBS): a new pattern of nerve stimulation to identify residual neuromuscular block. Br J Anaesth. 1989;62:274–8.
47. Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology. 2003;98:1042–8.
48. Baillard C, Clec’h C, Catineau J, Salhi F, Gehan G, Cupa M, Samama CM. Postoperative residual neuromuscular block: a survey of management. Br J Anaesth. 2005;95:622–6.
49. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS, Nisman M. Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit. Anesthesiology. 2008;109:389–98.
50. Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Marymont JH, Vender JS, Gray J, Landry E, Gupta DK. Intraoperative acceleromyography monitoring reduces symptoms of muscle weakness and improves quality of recovery in the early postoperative period. Anesthesiology. 2011;115:946–54.
51. Todd MM, Hindman BJ, King BJ. The implementation of quantitative electromyographic neuromuscular monitoring in an academic anesthesia department. Anesth Analg. 2014;119:323–31.